Management of Ventilator-Associated Pneumonia: Guidelines

Clin Chest Med. 2018 Dec;39(4):797-808. doi: 10.1016/j.ccm.2018.08.002.


Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment.

Keywords: Guideline; Hospital-acquired pneumonia; Nosocomial pneumonia; Ventilator-associated pneumonia.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Guidelines as Topic
  • Humans
  • Pneumonia, Ventilator-Associated / pathology
  • Pneumonia, Ventilator-Associated / therapy*


  • Anti-Bacterial Agents